Who Paid My Doc
Afshan Khan
Neurology with Special Qualifications in Child Neurology Bronx, NY Medical Doctor
NPI 1184812257 CMS profile 99414
1654 Mayflower Ave, Bronx, Bronx, NY 10461
General payments
$2,644
Research payments
$490
Ownership & investment interest
$0
Through program year 2025, Afshan Khan of Bronx, NY is reported in the CMS Open Payments database as having received $2,644 across 41 general payments and $490 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 68th percentile of Neurology with Special Qualifications in Child Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
8 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $141 | 2 | |
| 2024 | General | $1,309 | 1 | |
| 2023 | General | $18 | 1 | |
| 2022 | General | $205 | 7 | |
| 2021 | General | $67 | 4 | |
| 2020 | General | $37 | 2 | |
| 2020 | Research | $490 | 1 | |
| 2019 | General | $867 | 24 |
Beside peers
- Afshan Khan
- Neurology with Special Qualifications in Child Neurology median
- Middle half of Neurology with Special Qualifications in Child Neurology
- National median
In program year 2025, general payments to Afshan Khan were reported at $141. Among 1,228 Neurology with Special Qualifications in Child Neurology profiles paid that year, the median was $276 and the middle half received between $87 and $1,522.
Show as a table
| Year | Afshan Khan | Neurology with Special Qualifications in Child Neurology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $867 | $262 | $68–$1,313 | $163 |
| 2020 | $37 | $188 | $46–$1,222 | $114 |
| 2021 | $67 | $183 | $45–$1,356 | $132 |
| 2022 | $205 | $229 | $72–$1,177 | $149 |
| 2023 | $18 | $269 | $93–$1,195 | $160 |
| 2024 | $1,309 | $300 | $98–$1,428 | $164 |
| 2025 | $141 | $276 | $87–$1,522 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
42 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neurology with Special Qualifications in Child Neurology in New York
Claudia Chiriboga
Neurology with Special Qualifications in Child Neurology · New York, NY
Eric Segal
Neurology with Special Qualifications in Child Neurology · N White Plains, NY
Kaleb Yohay
Neurology with Special Qualifications in Child Neurology · New York, NY
Heather Lau
Neurology with Special Qualifications in Child Neurology · New York, NY
Louis Manganas
Neurology with Special Qualifications in Child Neurology · East Setauket, NY
Darryl Devivo
Neurology with Special Qualifications in Child Neurology · New York, NY
Related records
Neurology with Special Qualifications in Child Neurology in New York
Practitioners in the same specialty and state, ranked by reported value.
All Neurology with Special Qualifications in Child Neurology
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.